Current and Emerging Antiarrhythmic Drug Therapy for Ventricular Tachycardia

Ventricular arrhythmias, including ventricular fibrillation (VF) and sustained ventricular tachycardia (VT), are the principal causes of sudden cardiac death in patients with structural heart disease. While coronary artery disease is the predominant substrate associated with the development of VT, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Eric S., Viswanathan, Mohan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107437/
https://www.ncbi.nlm.nih.gov/pubmed/25135287
http://dx.doi.org/10.1007/s40119-013-0012-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107437/
https://www.ncbi.nlm.nih.gov/pubmed/25135287
http://dx.doi.org/10.1007/s40119-013-0012-5

Ejemplares similares